Literature DB >> 19479616

Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone.

Emanuele Ammatuna, Enrico Montefusco, Matteo Pacilli, Mariadomenica Divona, Davide Ardiri, Diego Centonze, Francesco Lo-Coco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19479616     DOI： 10.1080/10428190902912486

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

1.  Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy.

Authors:  Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2009-07

2.  Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan.

Authors:  Ching-Piao Tsai; Charles Tzu-Chi Lee
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.